Comparison of Pre-Mixed Human Insulin with Insulin Analog in Diabetic Control at Tertiary Care Hospital
DOI:
https://doi.org/10.51253/pafmj.v74i1.8855Keywords:
Blood glucose, Insulin analog, Mixed human insulin, Type-2 DM, Glycemic control, Glycated hemoglobinAbstract
Objective: To compare the effect of pre-mixed human insulin with insulin analogue in diabetic control among type-2 Diabetes mellitus patients at tertiary care hospital.
Study Design: Comparative cross-sectional study.
Place and Duration of Study: Department of Medicine, Pak Emirates Military Hospital, Rawalpindi, Pakistan, from Jun 2021
to Apr 2022.
Methodology: Eleven hundred and fifty-six patients with poorly controlled type-2 diabetes on oral hypoglycemic agents
requiring insulin were recruited for the study. Patients were divided into two groups via a lottery method. Group-A received
the pre-mixed human insulin, while Group-B received the Insulin analogue advised by the consultant endocrinologist or
medical specialist according to the requirements based on recent investigations. Diabetes control was compared in both
groups at the end of twelve weeks of treatment.
Results: Out of 1156 patients with type-2 diabetes mellitus included in the study, 810(70.1%) were male, while 346(29.9%) were female. The mean duration of DM in the study participants was 3.42±4.44 years. At the end of three months, 978(84.6%) patients had good glycemic control, while 178(15.4%) patients had poor glycemic control. Statistical analysis revealed that the type of insulin used to manage these patients had no significant relationship with glycemic control in our study participants (p-value>0.05).
Conclusion: No statistically significant difference was observed in the number of patients achieving adequate glycemic control between those using pre-mixed human insulin and those using insulin analogue in our study.
Downloads
References
Uloko AE, Musa BM, Ramalan MA, Gezawa ID, Puepet FH,
Uloko AT, et al. Prevalence and Risk Factors for Diabetes
Mellitus in Nigeria: A Systematic Review and Meta-Analysis.
Diabetes Ther 2018; 9(3): 1307-1316.
https://doi.org/10.1007/s13300-018-0441-1.
Bullard KM, Cowie CC, Lessem SE, Saydah SH, Menke A, Geiss
LS, et al. Prevalence of Diagnosed Diabetes in Adults by Diabetes
Type - United States, 2016. MMWR Morb Mortal Wkly Rep 2018;
(12): 359-361. https://doi.org/10.15585/mmwr.mm6712a2.
Al Mansari A, Obeid Y, Islam N, Fariduddin M, Hassoun A,
Djaballah K, et al. GOAL study: clinical and non-clinical
predictive factors for achieving glycemic control in people with
type 2 diabetes in real clinical practice. BMJ Open Diabetes Res
Care 2018; 6(1): e000519.
https://doi.org/10.1136/bmjdrc-2018-000519.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK.
Significance of HbA1c Test in Diagnosis and Prognosis of
Diabetic Patients. Biomark Insight 2016; 11: 95-104.
https://doi.org/10.4137/BMI.S38440.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK.
Significance of HbA1c Test in Diagnosis and Prognosis of
Diabetic Patients. Biomark Insight 2016; 11: 95-104.
https://doi.org/10.4137/BMI.S38440.
Hirsch IB, Juneja R, Beals JM, Antalis CJ, Wright EE. The
Evolution of Insulin and How it Informs Therapy and Treatment
Choices. Endocr Rev 2020; 41(5): 733–55.
https://doi.org/10.1210/endrev/bnaa015.
Qayyum R, Bolen S, Maruthur N, Feldman L, Wilson LM,
Marinopoulos SS, et al. Systematic review: comparative
effectiveness and safety of premixed insulin analogues in type-2
diabetes. Ann Intern Med 2008; 149(8): 549-559.
https://doi.org/10.7326/0003-4819-149-8-200810210-00242.
Margaritidis C, Karlafti E, Kotzakioulafi E, Kantartzis K,
Tziomalos K, Kaiafa G, et al. Comparison of Premixed Human
Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients
with Type-2 Diabetes Using Continuous Glucose Monitoring. J
Clin Med 2021; 10(9): 1982.
https://doi.org/10.3390/jcm10091982.
Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A,
Horvath K. (Ultra-)long-acting insulin analogues versus NPH
insulin (human isophane insulin) for adults with type-2 diabetes
mellitus. Cochrane Database Syst Rev 2020; 11(11): CD005613.
https://doi.org/10.1002/14651858.CD005613.pub4.
Hassan MI, Aamir AH, Miyan Z, Siddiqui LA, Mahmood S,
Vohra EA, et al. Switch from biphasic human insulin 30 to
biphasic insulin aspart 30 in Pakistani subjects. J Pak Med Assoc
; 63(10): 1290-1294.
Bardisi WM, Khorsheed MM, Magliah F, Magliah AF. Efficacy of
insulin analogues in diabetic patients attending primary care
centers. Saudi Med J 2015; 36(7): 829-833.
https://doi.org/10.15537/smj.2015.7.11409.
Lim WY, Ma S, Heng D, Tai ES, Khoo CM, Loh TP. Screening for
diabetes with HbA1c: Test performance of HbA1c compared to
fasting plasma glucose among Chinese, Malay and Indian
community residents in Singapore. Sci Rep 2018; 8(1): 12419.
https://doi.org/ 10.1038/s41598-018-29998-z.
Silver B, Ramaiya K, Andrew SB, Fredrick O, Bajaj S, Kalra S, et
al. EADSG Guidelines: Insulin Therapy in Diabetes. Diabetes
Ther 2018; 9(2): 449-492.
https://doi.org/10.1007/s13300-018-0384-6.
Haase CL, Eriksen KT, Lopes S, Satylganova A, Schnecke V,
McEwan P, et al. Body mass index and risk of obesity-related
conditions in a cohort of 2.9 million people: Evidence from a UK
primary care database. Obes Sci Pract 2020; 7(2): 137-147.
https://doi.org/ 10.1002/osp4.474.
Nicolucci A, Ceriello A, Di Bartolo P, Corcos A, Orsini Federici
M. Rapid-Acting Insulin Analogues Versus Regular Human
Insulin: A Meta-Analysis of Effects on Glycemic Control in
Patients with Diabetes. Diabetes Ther 2020; 11(3): 573-584.
https://doi.org/10.1007/s13300-019-00732-w.
Melo KFS, Bahia LR, Pasinato B, Porfirio GJM, Martimbianco AL,
Riera R, et al. Short-acting insulin analogues versus regular
human insulin on postprandial glucose and hypoglycemia in
type-1 diabetes mellitus: a systematic review and meta-analysis.
Diabetol Metab Syndr 2019; 11: 2.
https://doi.org/10.1186/s13098-018-0397-3.
Fullerton B, Siebenhofer A, Jeitler K, Horvath K, Semlitsch T,
Berghold A, et al. Short-acting insulin analogues versus regular
human insulin for adult, non-pregnant persons with type-2
diabetes mellitus. Cochrane Database Syst Rev 2018; 12(12):
CD013228. https://doi.org/10.1002/14651858.CD013228.
Yamada S, Watanabe M, Kitaoka A, Shiono K, Atsuda K,
Tsukamoto Y, et al. Switching from premixed human insulin to
premixed insulin lispro: a prospective study comparing the
effects on glucose control and quality of life. Intern Med. 2007;
(18):1513-1517.
Downloads
Published
Issue
Section
How to Cite
